Thursday, May 3, 2018

Endologix Names New CEO

Irvine-based Endologix, which develops treatments for aortic disorders, said on Wednesday that it has named John Onopchenko as the company's new Chief Executive Officer. Onopchenko had been the company's Chief Operating Officer since October of 2017. He previously had been EVP foR Acutus Medical, and also served at Volcano Corporation, Philips, and Johnson & Johnson, among what the company says is almost thirty years of experience in the medical devices area.